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The  close  association  of  the  group  a  allotypic  specificities  of  the  rabbit 
with  the variable  regions of the  different classes  of heavy (H)  1 chains poses 
problems  in  understanding  the  nature  of  genetic  control  mechanisms  (1). 
The amino acid compositions of the H chain variable (V) regions of homologous 
IgG and  IgM  antibodies correlate with  their group  a  allotypes  (2).  Correla- 
tions of allotype with V~ sequences also exist for both IgG (3-5) and IgA (6). 
While the precise amino acid changes responsible for determining the individual 
group a allotypes remain unknown, they must exist in close proximity to those 
structural  variations which  determine  the  antigen-binding  site  and  the idio- 
typic  marker.  These  variations  could,  in  a  given  homogeneous  antibody, 
modulate the antigenic properties of the allotypic specificities in the variable 
region. 
This report describes a  study of the group a  allotypic markers present on 
homogeneous  antibodies.  Differences  in  the  ability  of  these  antibodies  to 
absorb antisera against the group a  allotypes have been found. These results 
suggest that each group a allotype finds expression as  an array of specificities 
of which  only a  limited number are  expressed on individual  antibody mole- 
cules.  This situation is  in  contrast to  that  described for the  light  (L)  chain 
allotype b4  (7).  Complete b4 specificities are  expressed by individual  homo- 
geneous antibodies, which suggests that these  specificities are  located  within 
the constant region of the b4 L  chains,  an interpretation consistent with the 
findings  of Appella et al.  (8)  and  Frangione  and  Lamm  (9). 
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Materials and Methods 
The preparation of streptococcal vaccines, immunization of rabbits, serologic techniques, 
and cellulose acetate electrophoresis of sera have been described by Krause (10).  Antibodies 
to  Group  C  streptococcal polysaccharide were  isolated on  immunoabsorbent columns  and 
further  purified  by  agarose  block  electrophoresis  (11).  The  antipneumococcal  antibodies 
were a  generous gift from Dr. A.  D.  Strosberg. Disk electrophoresis in urea polyacrylamide 
gels was performed according to the method of Reisfeld and Small  (12).  Purified antibody 
and IgG preparations were radioiodinated by the iodine monochloride method of  McFarlane 
(13)  or by the chloramine T  method of McConahey and Dixon  (14).  Antlallotype sera  were 
prepared according to the principles of Oudin (15). Pooled rabbit IgG was isolated by column 
chromatography on Whatman DE52  DEAE-cellulose in 0.02  M  phosphate buffer, pH  7.0, 
after exhaustive dialysis of the pooled serum against this buffer. 
Quantitalion  of  Allolypic  Specificity.--The  percentage  of  antibody  molecules  carrying 
group a allot3q)ic  specificities was determined by radioimumne assay employing antiallotype 
sera  insolubilized by treatment with ethyl chloroformate  as  described  by  Avrameas  and 
Ternynck (16). To each of a series of microfuge tubes was added 0.5/zg  of antibody or  IgG 
tagged with 125I in  saline buffered with 0.02  M  phosphate to pH  7.9  and containing  1% 
bovine serum albumin (PBSA). This solution also contained sufficient 22Na to provide ini- 
tially 40,000  cpm to serve as an indicator of residual supernatant (17).  Incremental amounts 
of insolubilized antiserum were added to determine the amount required for maximal binding 
(Fig.  1), and the total volumes equalized by addition of PBSA as required. After incubation 
for 2.5 h  with gentle agitation, the tubes were centrifuged in a  Beckman microfuge  (Beck- 
man Instruments, Inc.,  Spinco  Div.,  Palto Alto,  Calif.),  most  of the supernatant was  re- 
moved, and the residue counted in a crystal scintillation counter. Each preparation of iodinated 
material was checked  for complete precipitability with insolubilized goat  antirabbit  Fc-  7 
and also with 10% trichloroacetic acid. 
Inhibition  Assays.--By  reference to  the  allotype  quantification curves described  above 
an amount of insolubilized antiallotype serum sufficient to  bind approximately 40%  of the 
test  amount  of  radioiodinated  standard  was  selected.  To  this  amount  of  antiserum  in  a 
series of microfuge  tubes  was  added  incremental  (usually doubling)  amounts  of  inhibitor. 
After mixing, the radiolabeled standard  and  22Na were added  and the final volumes were 
equalized with PBSA. After an additional incubation for 2.5 h  with gentle agitation, most of 
the supernatant was  aspirated,  and the  residue counted  in  a  crystal scintillation counter. 
The percent inhibition, %I, was calculated using the formula 
[  Pq,  %i=100  1-pod 
where  Po is  percent  of  1~I precipitated in the absence of inhibitor, and P,  is  the  percent 
precipitated in the presence of inhibitor. 
RESULTS 
Group  a  allotypes  have  antigenic  determinants  in  the  variable  region  of 
antibody  H  chains  (1-6).  Studies  were  designed  to  determine  whether  the 
expression  of  the  antigenic  determinant  of  a  given  group  a  allotype  would 
vary  in different antibodies.  Initial  experiments were  carried out with  several 
Group  C  streptococcal  antibodies.  Their L  chains  were  homogeneous  by  sev- 
eral  criteria,  including  disk  gel  electrophoresis  and  amino  acid  sequence  at 
the  amino  terminus.  Homogeneity  of  the  H  chains  was  indicated  by  allelic T.  KINDT~  R.  SEIDE,  B.  TACK,  AND  C.  TODD 
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FIG. 1.  Binding of radiolabeled a3/b4 IgG pool, a3/b4 3413 antibody, a3/b4 4135 anti- 
body, and preimmune a2,3/b4 4135 IgG. Each point represents 0.5/~g of radiolabeled sample 
with the designated  amount of anti-a3. 
exclusion  with  respect  to  group  a  allotypes,  as  well  as  by  electrophoretic 
homogeneity of the  antibody. 
Fig.  1 depicts the binding of radiolabeled a3/b4 antibodies 3413  and 4135, 
an  a3/b4  IgG pool,  and preimmune IgG from rabbit 4135,  that  carried  the 
allotypes  a2,  3/b4.  Increasing  amounts  of  anti-a3  were  added  to  constant 
amounts of ~25I-labeled samples. The slower rise in the curve for 4135 antibody 
(Ab) suggests a  lesser binding efficiency than that of 3413  Ab. The latter  in 
turn would be somewhat less efficiently bound than the a3/b4 IgG pool. The 
preimmune IgG from the heterozygous a2,3/b4 rabbit 4135 binds as efficiently 
as the a3/b4 pool but levels off at 55 %. This is because the IgG in this sample 
includes molecules of a2 specificity as well as those which carry no detectable 
group a marker (18,  19). 36  GROUP  a  ALLOTYPE SPECIFICITIES ON  RABBIT ANTIBODIES 
These  differences  in  the  capacities  of  homogeneous  antibodies  to  bind  to 
the anti-a3 were examined in greater detail. Inhibition of binding experiments 
utilized unlabeled  antibodies  and IgO  preparations  to inhibit the binding  of 
various  ~2SI-labeled preparations  to  the  ECF  antiallotype  sera.  In  Fig.  2  are 
depicted the results of inhibition of binding of a3/b4 t25I.IgG  to ECF  anti-a3 
by  the  unlabeled  IgG,  three  homogeneous  antibodies,  and  the  preimmune 
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I:lo. 2.  Left frame:  inhibition of binding of radiolabeled  a3/b4 IgG pool to ECF  anti-a3 
by a3/b4 IgG pool, by a3/b4 homogeneous antibodies 3413, 3521, and 4135, and  by a2,3/b4 
4135 preimmune IgG. The  amount  of  inhibitor  added was adjusted  to  give  the  indicated 
amount of a]lotype-bearing antibody as indicated by radiobinding assay. Right frame:  same 
except a different  anti-a3 serum was used. 
IgG from one of the rabbits  (4135)  that produced a homogeneous component 
used  in  this experiment.  In  all  the inhibition studies  reported  in  this paper 
the  amount  of  antibody  carrying  the  cognate  allotype  was  first  determined 
by binding studies such as those presented in Fig.  1. The amount of inhibitor 
added was then adjusted to provide the indicated amount of allotype-bearing 
molecules  on  the  basis  of  the  initial  binding  experiments.  This  procedure 
enabled comparisons  to be made with antibody preparations containing some 
molecules either allotypically blank or bearing some allelic allotype. 
The inhibition curves in Fig. 2 clearly show that the homogeneous antibodies 
have an antigenic deficiency compared to the IgG samples.  Further, there are T.  KINDT,  R.  SEIDE~  B.  TACK,  AND  C.  TODD  37 
differences  in the  extent  to which  the homogeneous antibodies  inhibit  the  a3 
IgG binding.  It is important  to note  that,  while  4135 Ab does not carry the 
complete  spectrum  of  a3  antigenic  determinants,  the  IgG  from  this  rabbit 
does not differ significantly from the pool. 
Fig.  2 right  gives the  data  obtained  by repeating  the  experiment  of Fig.  2 
left  using a  second anti-a3  produced in  a  rabbit  unrelated  to that producing 
the  first  anti-a3.  The  results  are  similar  to those obtained with the first anti- 
a3  used in the experiment shown in Fig 2  left. While the degrees of inhibition 
by the  homogeneous  antibodies  vary somewhat,  the  immunologic  deficiency 
of the homogeneous antibodies is again seen.  Similar results were obtained with 
other  anti-a3  sera  produced  in  either  The  Rockefeller  University  or  City of 
Hope rabbit colony. 
The  generality  of limited  expression  of  a3  determinants  on  homogeneous 
antibodies  is  evident  from the  examples presented  in Table  I. The inhibitors 
were  tested  for their  ability  to inhibit  binding of a3  IgG by adding them in 
32-fold excess over the radiolabeled  IgG to be inhibited.  It can be seen in the 
right hand column of Table  I  that  the  IgG preparations  gave approximately 
90 %  inhibition  of binding  regardless  of the  source.  The  possibility  that  the 
TABLE I 
Inhiblton of Binding of a3/b4 i25I X  IgG to ECF Anti-a3 
Allotype of  Percent  Rabbit  AUotype of rabbit  Inhibitor preparation*  preparation:~  inhibition§ 
Pool  al,3/b5  IgG  al,3/b5  87 
BH16301  a3/b5  IgG  a3/b5  91 
3500  a3/b4  IgG  a3/b4  92 
Ab-A1  a3/b4  73 
Ab-A2  a3/b4  70 
4135  a2,3/b4  IgG  a2,3/b4  87 
Ab-C  a3/b4  40 
3521  a2,3/b4  IgG  a2,3/b4  90 
Ab-C  a3/b4  40 
3498  al,3/b4  Antiovalbumin  al,3/b4  93 
3443  a3/b4  Ab-A1  a3/b4  58 
Ab-A2  a3/b4  50 
3413  a2,3/b4  Ab-C  a3/b4  60 
3582  a3/b4  Ab-A  a3/b4  69 
4153  a3/b9  Ab-C  a3/b9  50 
269911  a3/b5  Ab-Pn  a3/b5  49 
3351 II  a3/b5  Ab-Pn  a3/b5  85 
* The designation A or C after Ab indicated antibodies to components of Group A or C 
streptococci. Pn indicates antipneumococcal antibody. 
All inhibitor  preparations  were added in 32-fold excess of the radiolabeled a3,b4 IgG. 
When preparations containing two allotypes were used, a 32-fold excess of a3 IgG was added. 
§ The tube containing no inhibitor was 0% inhibition. 
[I These antibodies were the kind gift of Dr. A. D. Strosberg. Antibody 2699 is homogeneous 
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effects depicted  above arise  from selection  between  allelic  a3  variants is un- 
likely  because  the  IgG  from  the  highly  inbred  rabbit  BH16301  (from  the 
Jackson Laboratory, Bar Harbor, Maine)  carries  as complete an array of a3 
specificities  as  does  the  IgG  pool.  The  limited  specificities  of  homogeneous 
Group A streptococcal antibodies and the pneumococcal antibodies is a further 
indication of the generality of this phenomenon. All homogeneous a3 Ab thus 
far tested have expressed an incomplete a3 specificity. 
Another  question  examined  was whether  or not  the  specificities on  the  a3 
homogeneous  antibodies  represent  an  identical  subpopulation.  This  was 
investigated by examining the inhibition of binding of homogeneous antibodies 
with  other homogeneous antibodies.  Fig.  3 A  gives the  inhibition  curves ob- 
tained when the binding of ~25I 4135  antibody was inhibited with the  IgG pool 
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FIG. 3.  (A) Inhibition of binding of radiolabeled a3/b4 4135 streptococcal antibody  to 
ECF anti-a3 by a3/b4 IgG pool and homogeneous antibodies a3/b5 2699, a3/b4 3521, and 
a3/b4 4135. (B) Same as (A) except antibody inhibited was a3/b5 2699 pneumococcal  anti- 
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and  the  homogeneous  antibodies  2699,  3521,  and  4135.  While  no  striking 
differences are seen in the ability of the antibodies to inhibit this binding, the 
antibodies 3521  and 2699 were somewhat less effective as inhibitors than 4135 
antibody or a3/b4 IgG.  Greater differences in inhibition patterns are evident 
in Fig. 3 B, which presents the inhibition of binding of 125I 2699 pneumococcal 
antibody  to  anti-a3  by unlabeled  2699,  a3  IgG pool,  and  by  the  antibodies 
4135 and 3521. The latter two antibodies are much less effective inhibitors than 
2699 or a3 IgG pool. The results shown in Fig. 3 suggest that all homogeneous 
antibodies  do  not  express  the  same  limited  a3  specificity,  but  rather  each 
possesses certain  elements of a  spectrum of specificities. 
It is uncertain  how  many  different specificities there  are in  this spectrum, 
but  the  number  may  be  limited.  If  this  were  the  case,  a  small  group  of  a3 
homogeneous  antibodies  should  be  capable  of  complete inhibition  of  all  the 
specificities present in an a3 IgG pool. In Table II are listed the results of an 
experiment designed to test this postulate. In this experiment, three homogene- 
ous antibodies, alone and in various combinations, were used to inhibit binding 
of I~5I a3/b5 IgG to ECF anti-a3. The data support those presented in Fig. 3. 
The  a3  determinants  of 2699  are  complementary  to  those  of both  3521  and 
4135. It is further evident that 3521 and 4135 antibodies do not equally express 
a3 markers. In spite of the apparent complementarity of the a3 determinants 
of these  antibodies, all three together still do not express the entire spectrum 
of the a3 pool. 
In  additional  studies  limited  expression  of  the  specificities of  allotype  al 
and  a2 have  also been observed, although  there are not as many examples as 
for the a3 antibodies. Table III lists inhibition values given for the a2/b4 IgG 
TABLE II 
Complelnentation  of a3 Specificities  on Homogeneous Antibodies* 
Inhibitor  Amount  Inhibition of binding 
~g,*  % 
a3/b5 IgG  6  83 
4135 Ab  6  38 
3521 Ab  6  33 
2699 Ab  6  54 
a3/b5 IgG  12  89 
4135 Ab +  3521 Ab  6  +  6  44 
4135 Ab -[- 2699 Ab  6  -J-  6  64 
3521 Ab +  2699 Ab  6  ~-  6  65 
a3/b5 IgG  18  90 
4135 Ab +  3521 Ab -b 2699 Ab  6  ~  6  +  6  73 
* The inhibitors and the ECF anti-a3 were mixed and then the radiolabeled a3/b5 IgG, 
0.5 #g, was added. 
The amount of the inhibitor added was adjusted to give the indicated amount of allo- 
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TABLE  III 
Inhibition of Binding o! 12~I a2/b4 IgG to ECF Anti-a2* 
Allotype of  Rabbit  Allotype of rabbit  Inhibitor  preparation  preparation  Percent inhibition 
Pool  a2/b4  IgG  a2/b4  85 
3664  a2/b4  Ab-C  a2/b4  73 
4035  a2/b4  Ab-C  a2/b4  65 
* Abbreviations same as designated for Table I. 
pool and for two honiogeneous a2/b4 antibodies. The differences noted between 
these antibodies and the a2 IgG pool are significant, although not as great as 
some of the differences seen between the a3 antibodies and the a3 IgG samples. 
A similar result was obtained with an al pneumococcal antibody obtained from 
Dr. A. D.  Strosberg. These data suggest that a  diverse range of specificities 
are also associated with the other group a allotypes. 
DISCUSSION 
Antigenic variations in group a allotvpic specificities on homogeneous anti- 
bodies  directed  against  streptococcal  and  pneumococcal  polysaccharides 
have  been  observed.  The  homogeneous  antibodies  tested  expressed  only  a 
portion of the specificities exhibited by the total IgG of the rabbit even though 
these antibodies reacted completely with group a antisera. This latter property 
distinguishes  these antibodies with variations in group a  allotypic specificity 
from those antibodies which lack completely a group a allotype (18,  19). 
An explanation of the diverse expression of group a allotypes based on the 
assumption of allelic subpopulations is rendered unlikely by the finding that all 
total IgG preparations from individual  rabbits expressed the complete speci- 
ficity of the appropriate  alIotype. These samples included IgG from group a 
heterozygous individuals as well as IgG from a highly inbred rabbit from the 
Jackson Laboratory colony at Bar Harbor. That some specificities are common 
to individual antibodies was indicated by the experiments comparing homogene- 
ous antibodies to one another (Fig. 3). 
The range of specificities in the a3 pool was only partially reconstituted by a 
mixture of three different homogeneous antibodies. This limited reconstitution 
may  stem  from  the  fact  that  the  homogeneous antibodies  were  themselves 
directed against  the  narrow  range  of antigenic  specificities exhibited by the 
bacterial polysaecharides. Thus we believe that there is a basic conformation 
characteristic of each  allotype upon which  the  sequence changes  responsible 
for the  antibody combining  site  impose  modifications.  Indeed,  combination 
of an antibody with its antigen may produce further modifications of an allo- 
steric nature, although such an effect was not observed in the studies of Spring 
et al.  (20). While we have no way of estimating the precise number of speci- 
ficities that may exist, the  number must  be constrained by the necessity of 
avoiding cross-reaction with  the specificities arising from other group a  allo- T.  KINDT,  R.  SEIDE,  B.  TACK,  AND  C.  TODD  41 
types and by the fact that within a given allotype there will be cross-reacting 
specificities. The summation of all of these effects would be expected to elicit in 
individual antibodies a range of specificities which in some cases might approach 
the  total  expressed  in  the  IgG  pool.  Because  complete  homogeneity tests 
must ultimately rest on sequence studies, it  is not possible to distinguish be- 
tween complementation arising  from partial  heterogeneity in  the  antibodies 
tested and  a  high  degree of expression of the  range  of allotypic specificities 
which in principle could be exhibited by a completely homogeneous antibody. 
Our data show that antibodies directed against polyantigenic substances, such 
as ovalbumin, exhibit a complete range of specificities (Table I). In addition, 
the  studies  of Spring et al.  (20)  indicate  that  purified antibody populations 
directed  against  haptenic  antigens  express  the  complete  range  of  allotypic 
specificities.  None  the  less,  it  is  clear  from  the  studies  reported  here  that 
individual  antibodies  can  be  deficient with  respect  to  the  total  range  char- 
acteristic of an IgG pool. 
In contrast to the findings reported here with the group a allotypes, a previous 
study  (7)  indicated  that  homogeneous L  chains  carrying b4  allotypes were 
serologically indistinguishable even though these L chains showed considerable 
variation in  their amino terminal  sequences. This may be a  reflection of the 
different locations  of  the  group  a  and  b  allotype  determinants  within  the 
variable region of the H chains and the constant region of the L chains, respec- 
tively. Even though V~ region correlates have been observed (21,  22) for the 
group  b  allotypes,  the  determinants  are  most  likely  in  the  constant  (CL) 
region  (8,  9).  The  group  a  determinants  are  most  likely located in  the  VII 
region  (1  6), which places them in close proximity to the binding site deter- 
minants.  Thus  it  is  not  unexpected  that  differences in  binding  sites  would 
cause variable  expression of allotypic determinants. 
In spite of this proximity, the binding site may not participate directly in 
the group a determinant. Indeed, Spring et al. (20) showed that hapten antigens 
did not inhibit binding of antiallotype sera, whereas a  similar study utilizing 
antiidiotype sera  (23)  showed that the hapten would inhibit  this binding.  A 
more recent study  (24)  indicated that  there is  not an obligatory association 
between idiotypic and  group a  allotypic determinants.  Thus  the  amino  acid 
determinants of the group a specificities are probably distinct from the deter- 
minants  of the  binding  site.  The phenomenon observed here  is  more likely 
due  to conformational changes imposed by binding  site differences. Alterna- 
tively, it may reflect amino acid sequence variations in VH regions other than 
the binding site. If the latter interpretation is true, comparison of homogeneous 
antibody sequences  to  locate  the  amino  acid  residues  which  determine  the 
specificity of the allotypes will be complicated by these antigenic variants. 
SUMMARY 
Variations  in  the  ability  of  homogeneous  antibodies  to  absorb  group  a 
allotype antisera suggest that these Va region allotypes comprise a  spectrum 42  GROUP  a  ALLOTYPE SPECIFICITIES ON  RABBIT ANTIBODIES 
of  specificities.  While  no  homogeneous  antibody  tested  would  completely 
absorb  antisera  to  the  group  a  specificities, the  total  IgG preparations from 
individual  rabbits  was  capable  of  doing  so,  including  preimmune  IgG  from 
the rabbits that produced the homogeneous antibodies. 
Differences in  the  serologic reactivities of homogeneous  antibodies indicate 
that each possesses only a portion of the spectrum of the allotypic specifieities 
expressed bv  the  total  IgG. 
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